The evolution of fibrin-specific targeting strategies.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of materials chemistry. B

• Publication date

  2015-02-04

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1039/C4TB01769BPMID 29416866PMCID PMC5798253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.

  2015cited by this paper
• The role of molecular imaging in diagnosis of deep vein thrombosis.

  2014cited by this paper
• Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications.

  2014cited by this paper
• Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging

  2014cited by this paper
• Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.

  2014cited by this paper
• Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164

  2014cited by this paper
• Ultrasoft microgels displaying emergent, platelet-like, behaviors

  2014cited by this paper
• A fibrin-specific monoclonal antibody from a designed phage display library inhibits clot formation and localizes to tumors in vivo.

  2014cited by this paper
• SPECT imaging of fibrin using fibrin-binding peptides.

  2013cited by this paper
• Molecular MRI of Liver Fibrosis by a Peptide-Targeted Contrast Agent in an Experimental Mouse Model

  2013cited by this paper
• Fibrin-targeted PET probes for the detection of thrombi.

  2013cited by this paper
• Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.

  2013cited by this paper
• Evaluation of 111In-labeled EPep and FibPep as tracers for fibrin SPECT imaging.

  2013cited by this paper
• Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma☆

  2013cited by this paper
• Discovery of an uncovered region in fibrin clots and its clinical significance

  2013cited by this paper
• Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging.

  2012cited by this paper
• I and J

  2012cited by this paper
• Engineering fibrin polymers through engagement of alternative polymerization mechanisms.

  2012cited by this paper
• Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.

  2012cited by this paper
• Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.

  2012cited by this paper
• Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy

  2011cited by this paper
• Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide-PEG conjugates.

  2011cited by this paper
• A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.

  2011cited by this paper
• Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model.

  2011cited by this paper
• Perspectives and opportunities for nanomedicine in the management of atherosclerosis

  2011cited by this paper
• Roles of fibrin deposition and protease activated receptor-1 in renal cytokine/chemokine production and inflammatory cell infiltration in rats of different ages

  2011cited by this paper
• Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice

  2011cited by this paper
• Heteroditopic binding of magnetic resonance contrast agents for increased relaxivity.

  2011cited by this paper
• A new direction for anticoagulants: Inhibiting fibrin assembly with PEGylated fibrin knob mimics

  2011cited by this paper
• Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism.

  2010cited by this paper
• Engineering fibrin matrices: the engagement of polymerization pockets through fibrin knob technology for the delivery and retention of therapeutic proteins.

  2010cited by this paper
• Antibody fragments

  2010cited by this paper
• Nanoparticle-induced vascular blockade in human prostate cancer.

  2010cited by this paper
• Building better fibrin knob mimics: an investigation of synthetic fibrin knob peptide structures in solution and their dynamic binding with fibrinogen/fibrin holes.

  2010cited by this paper
• Multimodal nanoagents for the detection of intravascular thrombi.

  2009cited by this paper
• Thrombus Imaging With Fibrin-Specific Gadolinium-Based MR Contrast Agent EP-2104R: Results of a Phase II Clinical Study of Feasibility

  2009cited by this paper
• Fibrin gels and their clinical and bioengineering applications

  2009cited by this paper
• Targeting atherosclerosis by using modular, multifunctional micelles

  2009cited by this paper
• Improved neovascularization and wound repair by targeting human basic fibroblast growth factor (bFGF) to fibrin

  2008cited by this paper
• Monovalent and bivalent fibrin-specific MRI contrast agents for detection of thrombus.

  2008cited by this paper
• EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.

  2008cited by this paper
• Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.

  2007cited by this paper
• Biomimetic amplification of nanoparticle homing to tumors

  2007cited by this paper
• Platelet binding and biodistribution of [99mTc]rBitistatin in animal species and humans.

  2007cited by this paper
• Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.

  2007cited by this paper
• Phage display systems and their applications

  2006cited by this paper
• Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.

  2006cited by this paper
• Influence of cultivation temperature on the ligninolytic activity of selected fungal strains

  2006cited by this paper
• clinical investigations in critical care Time Course of Hemostatic Abnormalities in Sepsis and its Relation to Outcome *

  2006cited by this paper
• Imaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine.

  2006cited by this paper
• Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent

  2005cited by this paper
• Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer.

  2004cited by this paper
• Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.

  2004cited by this paper
• Γ and B

  2004cited by this paper
• Tissue factor and fibrin in tumor angiogenesis.

  2004cited by this paper
• Generation and characterization of a novel single-chain antibody fragment specific against human fibrin clots from phage display antibody library.

  2004cited by this paper
• Detection of experimental thrombi in rabbits with an131I-labelled fibrin-specific monoclonal antibody

  2004cited by this paper
• Labeling the thrombus: the future of nuclear medicine for venous thromboembolism?

  2004cited by this paper
• A Fast-acting, Modular-structured Staphylokinase Fusion with Kringle-1 from Human Plasminogen as the Fibrin-targeting Domain Offers Improved Clot Lysis Efficacy*

  2003cited by this paper
• Novel Factor XIII Probes for Blood Coagulation Imaging

  2003cited by this paper
• I and i

  2001cited by this paper
• Radiolabeled peptides in the detection of deep venous thrombosis.

  2001cited by this paper
• Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques

  2001cited by this paper
• Integrins α2β1 and α4β1 Can Mediate SA11 Rotavirus Attachment and Entry into Cells

  2000cited by this paper
• Catalytic Life of Activated Factor XIII in Thrombi: Implications for Fibrinolytic Resistance and Thrombus Aging

  2000cited by this paper
• Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa.

  2000cited by this paper
• Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

  2000cited by this paper
• Imaging vascular thrombosis with 99mTc-labeled fibrin alpha-chain peptide.

  2000cited by this paper
• Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.

  1999cited by this paper
• Antibodies against the fibrin beta-chain amino-terminus detect active canine venous thrombi.

  1997cited by this paper
• Recombinant Polypeptides Derived from the Fibrin Binding Domain of Fibronectin Are Potential Agents for the Imaging of Blood Clots

  1997cited by this paper
• Evaluation of the Fibrin Binding Profile of two Anti-fibrin Monoclonal Antibodies

  1996cited by this paper
• A New Thrombus Imaging Agent Human Recombinant Fibrin Binding Domain Labeled With In‐111

  1995cited by this paper
• Making antibodies by phage display technology.

  1994cited by this paper
• Imaging arterial thrombosis: comparison of technetium-99m-labeled monoclonal antifibrin antibodies and indium-111-platelets.

  1994cited by this paper
• 125I-Fibrinogen Leg Scanning: Reassessment of Its Role for the Diagnosis of Venous Thrombosis in Post-Operative Patients

  1993cited by this paper
• A monoclonal antibody which recognises an epitopic region unique to the intact fibrin polymeric structure

  1993cited by this paper
• Noninvasive Arterial Thrombus Imaging With 99mTc Monoclonal Antifibrin Antibody

  1992cited by this paper
• Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.

  1992cited by this paper
• Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids.

  1991cited by this paper
• Evaluation of indium-111-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic disease.

  1991cited by this paper
• Development of human anti‐murine antibody (HAMA) response in patients

  1990cited by this paper
• Detection of thrombophlebitis with 111In-labeled anti-fibrin antibody: preliminary results.

  1990cited by this paper
• The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies.

  1989cited by this paper
• Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.

  1987cited by this paper
• Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.

  1985cited by this paper
• Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.

  1984cited by this paper
• An immunoassay for human D dimer using monoclonal antibodies.

  1983cited by this paper
• Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen.

  1983cited by this paper
• Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.

  1980cited by this paper
• Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties.

  1980cited by this paper
• The diagnosis of deep vein thrombosis using the 125 I fibrinogen test.

  1972cited by this paper
• 125I-LABELLED FIBRINOGEN TEST ADAPTED FOR ROUTINE SCREENING FOR DEEP-VEIN THROMBOSIS

  1970cited by this paper
• 125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis.

  1970cited by this paper
• A and V

  1962cited by this paper
• and as an in

  year unknowncited by this paper
• AND T

  year unknowncited by this paper

• Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies

  2022cites this paper
• Modification of adipose mesenchymal stem cells-derived small extracellular vesicles with fibrin-targeting peptide CREKA for enhanced bone repair

  2022cites this paper
• Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective

  2022influential citation
• Smart Delivery of Plasminogen Activators for Efficient Thrombolysis; Recent Trends and Future Perspectives

  2021cites this paper
• Identification of and solution for false D‐dimer results

  2020cites this paper
• The Choice of Targets and Ligands for Site-Specific Delivery of Nanomedicine to Atherosclerosis.

  2020cites this paper
• Au-Cu@PANI Alloy Core Shells for Aerobic Fibrin Degradation under Visible Light Exposure.

  2020cites this paper
• Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles.

  2020cites this paper
• OP-CVRE200049 2055..2068

  2020cites this paper
• Fibrin Matrices as (Injectable) Biomaterials: Formation, Clinical Use, and Molecular Engineering.

  2019cites this paper
• Ocular adhesives: Design, chemistry, crosslinking mechanisms, and applications.

  2019cites this paper
• Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels.

  2018cites this paper
• What makes D‐dimer assays suspicious–heterophilic antibodies?

  2018cites this paper
• Weighing biointeractions between fibrin(ogen) and clot‐binding peptides using microcantilever sensors

  2017cites this paper
• Preparation of high-quality graphene with a large-size by sonication-free liquid-phase exfoliation of graphite with a new mechanism

  2015cites this paper
• Effect of immobilized α6β1 synthetic ligands on the behavior of oligodendrocyte progenitor cells (OPCs) in 3D fibrin hydrogels

  2015cites this paper
• Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.

  2014cites this paper